ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.

March 12, 2004

Freshman Congressman Launches Drive for “Adequate” Cancer Research Funding

August 5, 1983

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008